Sharon’s pushathon heads to Snetterton Circuit

4 min read

Brain Tumour Research supporter Sharon Mynard is due to finish her incredible wheelchair pushathon next month marking 40 years since she broke her neck in a horse riding accident. 

Sharon, who is in the final stages of her 2,795-mile virtual challenge to cover the equivalent distance around the coast of Great Britain, has dedicated her fundraising efforts to the renowned show horse producer Rory Gilsenan, who died of a glioblastoma (GBM) in April 2020 and her partner Tim Belfield who has had two low-grade meningiomas removed. 

As she approaches the final 170 miles of her epic event, tomorrow she will be pushing her way round the Snetterton Circuit in Norfolk after the qualifying day of the Intelligent Money British GT Championship. 

Race-Lab driver Iain Campbell, whose team requested permission from governing body SRO Motorsports Group for Sharon to take her pushathon to Snetterton, is planning to walk with her on the day. He is friends with the parents of Ethan Treharne, who died in November 2021, aged 17, two years after being diagnosed with a GBM. 

Sharon completed a push around our Head Office in April and last month, she did one around Centre:MK joined by 14 volunteers from NatWest who took part in wheelchairs provided by Age UK Milton Keynes. 

She is aiming to complete her epic challenge on Wednesday 26th July, 40 years to the day since, aged 16, she broke her neck in a horse riding accident, which left her confined to a wheelchair. By the time her pushathon comes to an end, Sharon will have been pushing for about 18 months, averaging more than two hours each day. 

Sharon (pictured with our Chief Executive Sue Farrington Smith MBE) said: “What I’m doing doesn’t compare to the pain of losing Rory, or what Tim has had to go through with this disease, but I’m hoping it will help raise awareness of the charity and much-needed funds for a very under-funded area of cancer research.” 

To support Sharon’s pushathon, please donate via her fundraising page:  

Related reading:

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.

Back to Latest News